Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zarate

Showing results (511-520 of 606) with videos related to

Pageof 61
Sort By:
Journal of Clinical Psychopharmacology|August 16, 2003
Olanzapine versus placebo in acute mania: treatment responses in subgroupsRoss J Baldessarini, John Hennen, Michael Wilson, et al.
Psychopharmacology|July 25, 2014
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depressionRuin Moaddel, David A Luckenbaugh, Ying Xie, et al.
Molecular Psychiatry|April 16, 2021
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liabilityJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Human Mutation|April 14, 2025
Quantitative Phenotype Morbidity Description of <i>SATB2</i>-Associated SyndromeYuri A Zarate, Katherine Bosanko, Amrit Kannan, et al.
Translational Psychiatry|November 19, 2025
Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory studyJenessa N Johnston, Peixiong Yuan, Bashkim Kadriu, et al.
Biological Psychiatry|November 25, 2010
Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging studyJonathan B Savitz, Allison C Nugent, Wendy Bogers, et al.
Molecular Psychiatry|May 31, 2017
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorderB Kadriu, P W Gold, D A Luckenbaugh, et al.
Journal of Medical Genetics|September 26, 2024
Pathogenic <i>SATB2</i> missense variants affecting p.Gly392 have variable functional implications and result in diverse clinical phenotypesJoery den Hoed, Hirokazu Hashimoto, Mubeen Khan, et al.
Journal of Psychiatric Research|September 25, 2012
Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in maniaRafael T de Sousa, Joao V Busnello, Orestes V Forlenza, et al.
Neuroscience and Biobehavioral Reviews|May 2, 2024
Exploring the impact of music on response to ketamine/esketamine: A scoping reviewMina Kheirkhah, Allison C Nugent, Alicia A Livinski, et al.
Pageof 61

Showing results (511-520 of 606) with videos related to

Sort By:
Pageof 61
Journal of Clinical Psychopharmacology|August 16, 2003
Olanzapine versus placebo in acute mania: treatment responses in subgroupsRoss J Baldessarini, John Hennen, Michael Wilson, et al.
Psychopharmacology|July 25, 2014
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depressionRuin Moaddel, David A Luckenbaugh, Ying Xie, et al.
Molecular Psychiatry|April 16, 2021
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liabilityJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Human Mutation|April 14, 2025
Quantitative Phenotype Morbidity Description of <i>SATB2</i>-Associated SyndromeYuri A Zarate, Katherine Bosanko, Amrit Kannan, et al.
Translational Psychiatry|November 19, 2025
Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory studyJenessa N Johnston, Peixiong Yuan, Bashkim Kadriu, et al.
Biological Psychiatry|November 25, 2010
Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging studyJonathan B Savitz, Allison C Nugent, Wendy Bogers, et al.
Molecular Psychiatry|May 31, 2017
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorderB Kadriu, P W Gold, D A Luckenbaugh, et al.
Journal of Medical Genetics|September 26, 2024
Pathogenic <i>SATB2</i> missense variants affecting p.Gly392 have variable functional implications and result in diverse clinical phenotypesJoery den Hoed, Hirokazu Hashimoto, Mubeen Khan, et al.
Journal of Psychiatric Research|September 25, 2012
Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in maniaRafael T de Sousa, Joao V Busnello, Orestes V Forlenza, et al.
Neuroscience and Biobehavioral Reviews|May 2, 2024
Exploring the impact of music on response to ketamine/esketamine: A scoping reviewMina Kheirkhah, Allison C Nugent, Alicia A Livinski, et al.
Pageof 61